Abeona Therapeutics (ABEO) PT Raised to $30 at Cantor Fitzgerald on FAYUVI Approval
Tweet Send to a Friend
Cantor Fitzgerald analyst Kristen Kluska raised the price target on Abeona Therapeutics (NASDAQ: ABEO) to $30.00 (from $28.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
